Page last updated: 2024-11-11

zearalenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

zearalenol: RN given refers to (3S-(3R*,7S*,11E))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5933650
SCHEMBL ID588699
SCHEMBL ID588698
MeSH IDM0094465

Synonyms (13)

Synonym
6-(10-hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid p-lactone
5916-52-9
zearalenol
SCHEMBL588699
SCHEMBL588698
FPQFYIAXQDXNOR-XVNBXDOJSA-N
(4s,8r)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one
NCGC00384542-01
(12e)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one
BCP11524
Z56763546
compound np-015244
AKOS040738786

Research Excerpts

Overview

α-zearalenol is a mycotoxin with a strong estrogen effect. It affects the synthesis and secretion of sex hormones. It is transported to target organs through human serum albumin (HSA)

ExcerptReferenceRelevance
"α-zearalenol (α-ZOL) is a mycotoxin with a strong estrogen effect that affects the synthesis and secretion of sex hormones and is transported to target organs through human serum albumin (HSA). "( Study of Competitive Displacement of Curcumin on α-zearalenol Binding to Human Serum Albumin Complex Using Fluorescence Spectroscopy.
Guo, T; Li, Y; Liu, X; Ma, L; Tan, H; Zhang, Y; Zhou, H; Zhou, Y, 2022
)
1.69

Toxicity

ExcerptReferenceRelevance
" The previous study demonstrated the toxic effects of ZEA and alpha-ZOL through disturbances in male fertility and other reproductive pathologies in mice."( Toxic effects of zearalenone and alpha-zearalenol on the regulation of steroidogenesis and testosterone production in mouse Leydig cells.
Cui, S; Wang, Y; Yang, J; Zhang, Y, 2007
)
0.61
" In conclusion, we demonstrate that ZEA or alpha-ZOL have adverse effects on reproductive system of adult male mice."( Toxic effects of zearalenone and its derivatives alpha-zearalenol on male reproductive system in mice.
Cui, S; Fan, JJ; Liu, JL; Wang, GX; Yang, JY,
)
0.38
" The feeding of naturally contaminated grains with ZEN was associated with hyperestrogenic and adverse effects on humans and animals."( Comparative study of toxic effects of zearalenone and its two major metabolites alpha-zearalenol and beta-zearalenol on cultured human Caco-2 cells.
Abid-Essefi, S; Bacha, H; Bouaziz, C; Golli-Bennour, EE; Ouanes, Z,
)
0.35
" The adverse effects of ZEN and its reductive metabolite α-zearalenol (α-ZEL) are often compared to those of 17β-estradiol (E2) and estrone (E1)."( Genotoxicity and inactivation of catechol metabolites of the mycotoxin zearalenone.
Fleck, SC; Hildebrand, AA; Metzler, M; Müller, E; Pfeiffer, E, 2012
)
0.62
"Two experiments were conducted to evaluate the efficacy of an activated diatomaceous clay (ADC) in reducing the toxic effects of zearalenone (ZEA) in the diet of rats and piglets."( Efficacy of activated diatomaceous clay in reducing the toxicity of zearalenone in rats and piglets.
Blandon, JC; Denli, M; Guynot, ME; Pérez, JF; Salado, S, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
" Fumonisin B1 (FB1) is a Fusarium mycotoxin frequently occurring in corn in combination with deoxynivalenol (DON), α-zearalenol (α-ZEA) and β-zearalenol (β-ZEA)."( Toxicological effects of fumonisin B1 alone and in combination with other fusariotoxins on bovine granulosa cells.
Albonico, M; Caloni, F; Cortinovis, C; Schütz, LF; Spicer, LJ, 2016
)
0.64
"01 nM) in combination with low concentrations of GEN, DAI and EQ (0."( Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones.
Betschler, A; Früholz, R; Grgic, D; Marko, D; Novak, B; Varga, E, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
"This study investigates the reduction of zearalenone (ZEA) and α-zearalenol (α-ZOL) on a solution model using allyl isothiocyanate (AITC) and also determines the bioaccessibility and bioavailability of the reaction products isolated and identified by MS-LIT."( Reaction of zearalenone and α-zearalenol with allyl isothiocyanate, characterization of reaction products, their bioaccessibility and bioavailability in vitro.
Bordin, K; Fernández-Blanco, C; Fernández-Franzón, M; Luciano, FB; Mañes, J; Meca, G; Ruiz, MJ; Saladino, F, 2017
)
0.98
" Results demonstrate complete presystemic hydrolysis of ZEN14G and ZEN14S to ZEN and high oral bioavailability for all administered compounds, with further extensive first-pass glucuronidation."( Insights into In Vivo Absolute Oral Bioavailability, Biotransformation, and Toxicokinetics of Zearalenone, α-Zearalenol, β-Zearalenol, Zearalenone-14-glucoside, and Zearalenone-14-sulfate in Pigs.
Broekaert, N; Callebaut, A; Catteuw, A; Croubels, S; De Baere, S; De Boevre, M; De Saeger, S; Devreese, M; Gasthuys, E; Gehring, R; Huybrechts, B; Ivanova, L; Lauwers, M; Uhlig, S, 2019
)
0.73
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
"Young female rats were orally dosed with either 1 or 100 mg zearalenone kg-1 body weight; zearalenone and metabolites were measured in a 96-h collection of urine and feces by HPLC analysis."( Zearalenone metabolism and excretion in the rat: effect of different doses.
Arbuckle, LD; Fitzpatrick, DW; Hassen, AM, 1988
)
0.27
" Dose-response curves for each mycotoxin were generated."( Effects of four Fusarium toxins (fumonisin B(1), alpha-zearalenol, nivalenol and deoxynivalenol) on porcine whole-blood cellular proliferation.
De Luna, R; Luongo, D; Russo, R; Severino, L, 2008
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (197)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (8.12)18.7374
1990's12 (6.09)18.2507
2000's59 (29.95)29.6817
2010's80 (40.61)24.3611
2020's30 (15.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.51 (24.57)
Research Supply Index5.42 (2.92)
Research Growth Index5.03 (4.65)
Search Engine Demand Index32.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (2.28%)5.53%
Reviews2 (0.91%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other212 (96.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]